| 1 |
Fenton C, Lyseng-williamson KA. Methadone is an option to treat cancer pain in carefully selected patients. Drugs Ther Perspect 2020;36:502-8. [DOI: 10.1007/s40267-020-00772-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Mammana G, Bertolino M, Bruera E, Orellana F, Vega F, Peirano G, Bunge S, Armesto A, Dran G. First-line methadone for cancer pain: titration time analysis. Support Care Cancer 2021;29:6335-41. [PMID: 33880639 DOI: 10.1007/s00520-021-06211-y] [Reference Citation Analysis]
|
| 3 |
Heung Y, Reddy A. How to Use Methadone in an Era of an Opioid Epidemic. Curr Treat Options Oncol 2020;21:30. [PMID: 32193644 DOI: 10.1007/s11864-020-0724-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Edmonds KP, Saunders IM, Willeford A, Ajayi TA, Atayee RS. Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations. Drugs 2020;80:115-30. [PMID: 31820362 DOI: 10.1007/s40265-019-01234-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Haas MF, Latchman J, Guastella AM, Craig DS, Chang YD. Lucid Dreams Associated with Pregabalin: Implications for Clinical Practice. J Pain Palliat Care Pharmacother 2022;:1-6. [PMID: 35759531 DOI: 10.1080/15360288.2022.2081754] [Reference Citation Analysis]
|
| 6 |
Willeford A, Atayee RS, Winters KD, Mesarwi P. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain. Journal of Pain & Palliative Care Pharmacotherapy 2019;32:248-55. [DOI: 10.1080/15360288.2019.1615028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Okayama S, Matsuda Y. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting. J Hosp Palliat Nurs 2021;23:539-43. [PMID: 34334770 DOI: 10.1097/NJH.0000000000000790] [Reference Citation Analysis]
|
| 8 |
Hanna V, Senderovich H. Methadone in Pain Management: A Systematic Review. The Journal of Pain 2021;22:233-45. [DOI: 10.1016/j.jpain.2020.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Irwin MN, Ellingrod VL, Smith MA. Pharmacogenetics of Methadone for Pain Management in Palliative Care. J Pain Symptom Manage 2021:S0885-3924(21)00519-4. [PMID: 34461232 DOI: 10.1016/j.jpainsymman.2021.08.007] [Reference Citation Analysis]
|
| 10 |
Smith MA, Quirk KC, Saul DC, Rodgers PE, Silveira MJ. Comparing Methadone Rotation to Consensus Opinion. J Pain Symptom Manage 2020;59:116-20. [PMID: 31560968 DOI: 10.1016/j.jpainsymman.2019.09.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Kreutzwiser D, Tawfic QA. Methadone for Pain Management: A Pharmacotherapeutic Review. CNS Drugs 2020;34:827-39. [DOI: 10.1007/s40263-020-00743-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Datta P, Kruk JS, Jordan K, Fisher KA. Dying with dignity: the challenges of end-of-life care in patients with substance use disorders. BMJ Case Rep 2021;14:e240945. [PMID: 34815225 DOI: 10.1136/bcr-2020-240945] [Reference Citation Analysis]
|
| 13 |
Madden K, Jo E, Williams JL, Liu D, Bruera E. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain. J Pain Symptom Manage 2019;58:678-84. [PMID: 31195079 DOI: 10.1016/j.jpainsymman.2019.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 14 |
Dziedzic KL, Albert RH. Management of Intractable Symptoms in Oncologic Care. Curr Oncol Rep 2021;23:93. [PMID: 34125305 DOI: 10.1007/s11912-021-01082-2] [Reference Citation Analysis]
|
| 15 |
Liu J, Smith KE, Riker RR, Craig WY, McKelvy DJ, Kemp HD, Nichols SD, Fraser GL. Methadone bioavailability and dose conversion implications with intravenous and enteral administration: A scoping review. Am J Health Syst Pharm 2021;78:1395-401. [PMID: 33872344 DOI: 10.1093/ajhp/zxab166] [Reference Citation Analysis]
|
| 16 |
Ramkiran S, Thota RS. Methadone in Cancer Pain. Indian J Palliat Care 2020;26:215-20. [PMID: 32874036 DOI: 10.4103/0973-1075.285690] [Reference Citation Analysis]
|
| 17 |
Biewald MA, Scarborough B, Lindenberger E. Methadone for Palliative Care Providers: A Case-Based Flipped Classroom Module for Faculty and Fellows. MedEdPORTAL 2021;17:11172. [PMID: 34395853 DOI: 10.15766/mep_2374-8265.11172] [Reference Citation Analysis]
|
